Intellia Therapeutics, Inc.
NTLA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $189 | $227 | $524 | $123 |
| Short-Term Investments | $412 | $685 | $669 | $625 |
| Receivables | $9 | $36 | $4 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $30 | $50 | $20 | $19 |
| Total Curr. Assets | $640 | $998 | $1,217 | $769 |
| Property Plant & Equip (Net) | $247 | $148 | $161 | $100 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $44 | $155 | $142 | $425 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $260 | $0 | $0 | $0 |
| Total NC Assets | $551 | $303 | $303 | $525 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,191 | $1,301 | $1,520 | $1,294 |
| Liabilities | – | – | – | – |
| Payables | $15 | $7 | $5 | $10 |
| Short-Term Debt | $20 | $19 | $17 | $9 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $21 | $22 | $44 | $64 |
| Other Curr. Liab. | $55 | $67 | $61 | $43 |
| Total Curr. Liab. | $111 | $115 | $127 | $126 |
| LT Debt | $190 | $97 | $114 | $65 |
| Deferred Rev, NC | $18 | $39 | $20 | $63 |
| Deferred Tax Liab, NC | $0 | -$39 | $0 | $0 |
| Other NC Liab. | $0 | $39 | $24 | $0 |
| Total NC Liab. | $208 | $136 | $158 | $128 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $210 | $115 | $131 | $74 |
| Total Liabilities | $319 | $251 | $285 | $254 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,177 | -$1,658 | -$1,177 | -$703 |
| AOCI | $1 | -$2 | -$7 | -$3 |
| Other Equity | $3,049 | $2,711 | $2,420 | $1,746 |
| Total Equity | $872 | $1,050 | $1,236 | $1,040 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,191 | $1,301 | $1,520 | $1,294 |
| Net Debt | $21 | -$111 | -$393 | -$49 |